Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Goldline Pharmaceutical Ltd.

May 19, 01:07 BSE 56.77 (+ 13.77 32.02%)

Volume984000

Prev. Close
43.00

Open Price
59.75

Today's Low / High

56.77 60.00

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
56.77 (342000)

52 Wk Low / High

0.00 0.00

Goldline Pharmaceutical Ltd.is not traded in NSE

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	69.00	23.00	20.00	20.00	20.00

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.90	2.30	2.00	2.00	2.00
Preference Share Capital	1.81	1.81	1.81	1.81	1.81
Total Share Capital	8.71	4.11	3.81	3.81	3.81

Reserves and Surplus	1.64	3.76	2.08	3.09	2.96
Total Reserves and Surplus	1.64	3.76	2.08	3.09	2.96
Total Shareholders Funds	10.35	7.86	5.89	6.89	6.77

NON-CURRENT LIABILITIES
Long Term Borrowings	3.19	4.05	3.81	5.89	4.45
Deferred Tax Liabilities [Net]	0.09	0.06	0.01	0.00	0.00
Other Long Term Liabilities	0.22	0.22	0.22	0.00	0.00
Long Term Provisions	0.66	0.57	0.46	0.00	0.00
Total Non-Current Liabilities	4.16	4.90	4.50	5.89	4.45

CURRENT LIABILITIES
Short Term Borrowings	7.84	7.08	7.02	4.42	5.37
Trade Payables	2.06	1.64	0.87	1.59	1.56
Other Current Liabilities	0.82	0.74	0.95	1.45	1.62
Short Term Provisions	1.06	0.70	0.17	0.00	0.00
Total Current Liabilities	11.77	10.17	9.00	7.47	8.55

Total Capital And Liabilities	26.28	22.93	19.39	20.25	19.77

ASSETS
NON-CURRENT ASSETS
Tangible Assets	2.84	2.92	2.47	2.10	2.14
Intangible Assets	0.05	0.04	0.03	0.03	0.03
Capital Work-In-Progress	0.00	0.45	0.00	0.00	0.00
Fixed Assets	2.89	3.40	2.50	2.13	2.17
Non-Current Investments	0.04	0.03	0.07	0.42	0.42
Total Non-Current Assets	2.93	3.43	2.57	2.55	2.59


CURRENT ASSETS
Inventories	6.78	7.49	5.37	5.46	6.07
Trade Receivables	10.69	9.62	8.63	8.69	8.48
Cash And Cash Equivalents	1.24	0.79	0.05	0.14	0.10
Short Term Loans And Advances	4.12	1.42	2.49	3.41	2.52
OtherCurrentAssets	0.52	0.18	0.28	0.00	0.00
Total Current Assets	23.35	19.50	16.82	17.71	17.18

Total Assets	26.28	22.93	19.39	20.25	19.77

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.77	0.00	0.00	0.00	0.00

BONUS DETAILS
Bonus Equity Share Capital	4.60	0.00	0.00	0.00	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	0.00	0.00	0.42	0.42

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	69.00

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.90
Preference Share Capital	1.81
Total Share Capital	8.71
Reserves and Surplus	1.64
Total Reserves and Surplus	1.64
Total Shareholders Funds	10.35
NON-CURRENT LIABILITIES
Long Term Borrowings	3.19
Deferred Tax Liabilities [Net]	0.09
Other Long Term Liabilities	0.22
Long Term Provisions	0.66
Total Non-Current Liabilities	4.16
CURRENT LIABILITIES
Short Term Borrowings	7.84
Trade Payables	2.06
Other Current Liabilities	0.82
Short Term Provisions	1.06
Total Current Liabilities	11.77
Total Capital And Liabilities	26.28
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2.84
Intangible Assets	0.05
Capital Work-In-Progress	0.00
Fixed Assets	2.89
Non-Current Investments	0.04
Total Non-Current Assets	2.93
CURRENT ASSETS
Inventories	6.78
Trade Receivables	10.69
Cash And Cash Equivalents	1.24
Short Term Loans And Advances	4.12
OtherCurrentAssets	0.52
Total Current Assets	23.35
Total Assets	26.28
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.77
BONUS DETAILS
Bonus Equity Share Capital	4.60
NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00